N
NeoPharm Co Ltd
KOSDAQ:092730
NeoPharm Co Ltd
KOSDAQ:092730
Price:
29 550 KRW
-0.51%
Market Closed
Updated:
Jun 8, 2024
NeoPharm Co Ltd
Research & Development
|
NeoPharm Co Ltd
Research & Development Peer Comparison
Comparables:
090430
002790
192820
051900
161890
Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
N
|
NeoPharm Co Ltd
KOSDAQ:092730
|
Research & Development
-₩2.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
|
AmorePacific Corp
KRX:090430
|
Research & Development
-₩104.3B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-5%
|
|
|
Amorepacific Group
KRX:002790
|
Research & Development
-₩105.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-5%
|
|
|
Cosmax Inc
KRX:192820
|
Research & Development
-₩79.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Research & Development
-₩27.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-13%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Research & Development
-₩28.3B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-54%
|
See Also
What is NeoPharm Co Ltd's Research & Development?
Research & Development
-2.7B
KRW
-2.7B
KRW
Based on the financial report for Mar 31, 2024, NeoPharm Co Ltd's Research & Development amounts to -2.7B KRW.
What is NeoPharm Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-5%
-5%
Over the last year, the Research & Development growth was 4%. The average annual Research & Development growth rates for NeoPharm Co Ltd have been 2% over the past three years , -1% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
